Elucidating the crystal structures,
transformations, and thermodynamics
of the two zwitterionic hydrates (Hy2 and HyA) of 3-(4-dibenzo[b,f][1,4]oxepin-11-yl-piperazin-1-yl)-2,2-dimethylpropanoic
acid (DB7) rationalizes the complex interplay of temperature, water
activity, and pH on the solid form stability and transformation pathways
to three neutral anhydrate polymorphs (Forms I, II°, and III).
HyA contains 1.29 to 1.95 molecules of water per DB7 zwitterion (DB7z). Removal of the essential water stabilizing HyA causes it
to collapse to an amorphous phase, frequently concomitantly nucleating
the stable anhydrate Forms I and II°. Hy2 is a stoichiometric
dihydrate and the only known precursor to Form III, a high energy
disordered anhydrate, with the level of disorder depending on the
drying conditions. X-ray crystallography, solid state NMR, and H/D
exchange experiments on highly crystalline phase pure samples obtained
by exquisite control over crystallization, filtration, and drying
conditions, along with computational modeling, provided a molecular
level understanding of this system. The slow rates of many transformations
and sensitivity of equilibria to exact conditions, arising from its
varying static and dynamic disorder and water mobility in different
phases, meant that characterizing DB7 hydration in terms of simplified
hydrate classifications was inappropriate for developing this pharmaceutical.